Delivery Order SPE2DB20D2014-SPE2DB25FC41T
- Not listed
- This is a $55,214.59 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for CELLCEPT 500 MG TABLET 500S. The contract has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,646.18 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a performance period ending on June 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,835.41 firm fixed-price contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract is not set aside and has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,894.49, is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The order is for CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, and has a ceiling value of $9,699.50. The contract is a Firm Fixed Price delivery order with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,461.25 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 100S. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a ceiling value of $22,139.10 and a period of performance ending on May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,856.14 firm fixed price contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract has a performance period through May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a $16,028.49 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on December 3, 2024. The contract provides for the delivery of 4,566,590,738 units of CellCept 500 mg tablets by December 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. This contract award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CELLCEPT 500 MG TABLET 500S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price of $12,126.51 and a completion date of June 26, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC41TDelivery Order
This is a $9,469.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 100S. The contract has a completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 7/9/25 |